2,723
Views
1
CrossRef citations to date
0
Altmetric
Editorial

When should screening for diabetic retinopathy begin for children with type 1 diabetes?

, &
Pages 97-102 | Received 13 Dec 2015, Accepted 20 Jan 2016, Published online: 12 Feb 2016

References

  • Hovind P, Tarnow L, Rossing K, et al. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care. 2003;26(4):1258–1264.
  • Klein R, Lee KE, Knudtson MD, et al. Changes in visual impairment prevalence by period of diagnosis of diabetes: the Wisconsin epidemiologic study of diabetic retinopathy. Ophthalmology. 2009;116(10):1937–1942.
  • Wong TY, Mwamburi M, Klein R, et al. Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis. Diabetes Care. 2009;32(12):2307–2313.
  • Romero-Aroca P, Fernández-Balart J, Baget-Bernaldiz M, et al. Changes in the diabetic retinopathy epidemiology after 14 years in a population of type 1 and 2 diabetic patients after the new diabetes mellitus diagnosis criteria and a more strict control of the patients. J Diabetes Complications. 2009;23(4):229–238.
  • Liew G, Michaelides M, Bunce C. A comparison of the causes of blindness certifications in England and Wales in working age adults (16-64 years), 1999-2000 with 2009-2010. BMJ Open. 2014;4(2):e004015-e004015.
  • Mohamed Q, Gillies MC, Wong TY. Management of diabetic retinopathy: a systematic review. JAMA. 2007;298(8):902–916.
  • Morgan CL, Owens DR, Aubonnet P, et al. Primary prevention of diabetic retinopathy with fibrates: a retrospective, matched cohort study. BMJ Open. 2013;3:e004025.
  • The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986.
  • White NH, Cleary PA, Dahms W, et al. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the diabetes control and complications trial (DCCT). J Pediatr. 2001;139:804–812.
  • Cho WB, Oh SB, Moon JW, et al. Panretinal photocoagulation combined with intravitreal bevacizumab in high-risk proliferative diabetic retinopathy. Retina. 2009;29(4):516–522.
  • Javitt JC, Aiello LP. Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med. 1996;124(1 Pt 2):164–169.
  • O’Hagan M, Harvey JN. Glycemic control in children with type 1 diabetes in wales: influence of the pediatric diabetes specialist nurse. Diabetes Care. 2010;33:1724–1726.
  • The Royal College of Ophthalmologists. Diabetic retinopathy guidelines. London: The Royal College of Ophthalmologists; 2012.
  • The Retinopathy Working Party. A protocol for screening for diabetic retinopathy in Europe. Retinopathy working party. Diabetic Med. 1991;8(3):263–267.
  • Karma A, et al. Diabeettinen retinopatia: seuranta hoito ja nakovammautuneen diabeetikon kuntoutus. Suomen Laakarilehti. 1992;24:2199–2211.
  • Swedish National Board of Health and Welfare. National guidelines for treatment of diabetes mellitus; 1999.
  • Kubin M, Tossavainen P, Hannula V, et al. Prevalence of retinopathy in Finnish children and adolescents with type 1 diabetes: a cross-sectional population-based retrospective study. Arch Dis Child. 2011;96:963–968.
  • Kernell A, Dedorsson I, Johansson B, et al. Prevalence of diabetic retinopathy in children and adolescents with IDDM. A population-based multicentre study. Diabetologia. 1997;40(3):307–310.
  • Donaghue KC, Fairchild JM, Chan A, et al. Diabetes microvascular complications in prepubertal children. J Pediatr Endocrinol Metab: JPEM. 1997;10(6):579–585.
  • Kullberg CE, Abrahamsson M, Arnqvist HJ, et al. Prevalence of retinopathy differs with age at onset of diabetes in a population of patients with type 1 diabetes. Diabetic Med: J British Diabetic Assoc. 2002;19(11):924–931.
  • Maguire A, Chan A, Cusumano J, et al. The case for biennial retinopathy screening in children and adolescents. Diabetes Care. 2005;28(3):509–513.
  • LeCaire T, Palta M, Zhang H, et al. Lower than expected prevalence and severity of retinopathy in an incident cohort followed during the first 4-14 years of type 1 diabetes: the Wisconsin diabetes registry study. Am J Epidemiol. 2006;164:143–150.
  • Flack A, Kaar ML, Laatikainen L. A prospective, longitudinal study examining the development of retinopathy in children with diabetes. Acta Paediatr. 1996;85(3):313–319.
  • Geloneck MM, Forbes BJ, Shaffer J, et al. Ocular complications in children with diabetes mellitus. Ophthalmology. 2015;122:2457–2464.
  • Cahill M, Wallace D, Travers S, et al. Detection and prevalence of early diabetic retinopathy in juvenile diabetics with diabetes for 10 years or more. Eye. 2000;14(Pt 6):847–850.
  • Demirel F, Tepe D, Kara O, et al. Microvascular complications in adolescents with type 1 diabetes mellitus. J Clin Res Pediatr Endocrinol. 2013;5:145–149.
  • Dujic MP, Ignjatović Z. Juvenile diabetes eye complications and treatment. Vojnosanit Pregl. 2009;66:729–732.
  • Florkowski CM, Scott RS, Coope PA, et al. Age at diagnosis, glycaemic control and the development of retinopathy in a population-based cohort of Type 1 diabetic subjects in Canterbury, New Zealand. Diabetes Res Clin Pract. 2001;52(2):125–131.
  • Holl RW, Lang GE, Grabert M, et al. Diabetic retinopathy in pediatric patients with type-1 diabetes: effect of diabetes duration, prepubertal and pubertal onset of diabetes, and metabolic control. J Pediatr. 1998;132(5):790–794.
  • Olsen BS, Sjølie AK, Hougaard P, et al. The significance of the prepubertal diabetes duration for the development of retinopathy and nephropathy in patients with type 1 diabetes. J Diabetes Complications. 2004;18(3):160–164.
  • Klein R, Klein BE, Moss SE, et al. Retinopathy in young-onset diabetic patients. Diabetes Care. 1985;8(4):311–315.
  • Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984;102(4):520–526.
  • Thomas RL, et al. Prevalence of diabetic retinopathy in persons with type 1 diabetes aged 12 to 18 years in the diabetic retinopathy screening service for Wales. Vancouver: International Diabetes Federation, World Diabetes Congress; 2015.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.